Table 1.
Characteristics | No. of Patient (n = 723) |
---|---|
Age | |
mean age (±SD) | 63.7 (±17.7) |
range | 2–95 |
≤60 | 255 (35.3%) |
61–80 | 369 (51.0%) |
>80 | 99 (13.7%) |
Sex | |
Female | 268 (37.1%) |
Male | 455 (62.9%) |
Race | |
White | 616 (85.2%) |
Black | 59 (8.2%) |
Asian or Pacific Islander | 42 (5.8%) |
American Indian | 3 (0.4%) |
Unknown | 3 (0.4%) |
Year | |
1980–1999 | 171 (23.7%) |
2000–2013 | 552 (76.4%) |
Laterality | |
Bilateral | 57 (7.9%) |
Left | 349 (48.3%) |
Right | 283 (39.1%) |
Unknown | 34 (4.7%) |
Stage | |
Stage I | 188 (26.0%) |
Stage II | 178 (24.6%) |
Stage III | 45 (6.2%) |
Stage IV | 263 (36.4%) |
Unknown | 49 (6.8%) |
Surgery | |
Surgery | 243 (33.6%) |
Non-surgery | 462 (63.9%) |
Unknown | 18 (2.5%) |
Histology | |
Hodgkin lymphoma | 5 (0.7%) |
Non-Hodgkin lymphoma | 674 (93.2%) |
DLBCL | 407 (56.3%) |
Follicular lymphoma | 65 (9.0%) |
Marginal zone lymphoma | 56 (7.8%) |
Burkitt’s lymphoma | 25 (3.5%) |
Small lymphatic lymphoma | 20 (2.8%) |
Continued | |
Characteristics | No. of Patient (n = 723) |
T/NK cell lymphoma | 10 (1.4%) |
Non-Hodgkin lymphoma, NOS | 91 (12.6%) |
Lymphoma, NOS | 44 (6.1%) |
Note: SD: standard deviation; DLBCL: diffuse large B-cell lymphoma; NOS: not otherwise specified.